Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 111Gastrointestinal 13Thoracic 12CNS 9Plasma cell 8Gynecologic 6Myeloid 4Other hematologic neoplasm 3Lymphoid 3Genitourinary 3Breast 3Sarcoma 1Other 1Head & Neck 1

Conditions

Head and Neck Neoplasms 1869Squamous Cell Carcinoma of Head and Neck 1109Nasopharyngeal Carcinoma 535Thyroid Neoplasms 518Mouth Neoplasms 347Oropharyngeal Neoplasms 292Laryngeal Neoplasms 197Neoplasms 187Carcinoma, Squamous Cell 187Breast Neoplasms 183Lung Neoplasms 181Nasopharyngeal Neoplasms 160Thyroid Nodule 154Salivary Gland Neoplasms 135Thyroid Cancer, Papillary 122Neoplasm Metastasis 113Carcinoma, Non-Small-Cell Lung 112Hypopharyngeal Neoplasms 111Melanoma 105Prostatic Neoplasms 99Esophageal Neoplasms 95Colorectal Neoplasms 90Thyroid Diseases 86Uterine Cervical Neoplasms 82Recurrence 81Pancreatic Neoplasms 79Ovarian Neoplasms 70Sarcoma 68Stomach Neoplasms 65Xerostomia 62

Interventions

apixaban 1Enoxaparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Venous Thromboembolism × Head & Neck × Clear all
NCT07189897 2025-10-08

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

State University of New York - Upstate Medical University

Phase 4 Recruiting
76 enrolled
Classical hematologyHead & Neck

Head and Neck Neoplasms, Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡